Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors.
Pérez-Lamas L, Luna A, Boque C, Xicoy B, Giraldo P, Pérez López R, Ruiz Nuño C, De Las Heras N, Mora Casterá E, López Marín J, Segura Díaz A, Gómez V, Vélez Tenza P, Sierra Pacho M, Vera Goñi JA, Moreno Vega M, Alvarez-Larrán A, Cortés M, Pérez Encinas M, Carrascosa Mastell P, Angona A, Rosell A, Lakhwani S, Colorado M, Ramila E, Cervero C, Cuevas B, Villalón Blanco L, de Paz R, Paz Coll A, Fernández MJ, Felipe Casado L, Alonso-Domínguez JM, Anguita Arance MM, Salamanca Cuenca A, Jiménez-Velasco A, Prendes SO, Santaliestra M, Lis Chulvi MJ, Hernández-Boluda JC, García-Gutiérrez V. Pérez-Lamas L, et al. Cancers (Basel). 2023 Feb 7;15(4):1045. doi: 10.3390/cancers15041045. Cancers (Basel). 2023. PMID: 36831388 Free PMC article.
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid.
Martín-Moro F, Núnez-Torrón C, Pérez-Lamas L, Jiménez-Chillón C, Marquet-Palomanes J, López-Jiménez FJ, Herrera-Puente P. Martín-Moro F, et al. Among authors: perez lamas l. Leuk Res. 2021 Feb;101:106518. doi: 10.1016/j.leukres.2021.106518. Epub 2021 Jan 27. Leuk Res. 2021. PMID: 33571876 Free PMC article. No abstract available.
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia.
Luna A, Pérez-Lamas L, Boque C, Giraldo P, Xicoy B, Ruiz Nuño C, Vega MM, Alvarez-Larrán A, Salamanca A, García-Noblejas A, Vall-Llovera F, Villalon L, De Las Heras N, Ramila E, Pérez-Encinas M, Cuevas B, Perez-Lopez R, Sanchez-Guijo F, Jiménez-Velasco A, Lakhwani S, Casado LF, Rosell A, Escola A, Fernández MJ, Garcia-Hernandez C, Cervero C, Mora E, Sagüés M, Suarez-Varela S, Vélez P, Carrascosa Mastell P, Bitaube RF, Serrano L, Cortes M, Vera Goñi JA, Steegmann JL, de Soria VGG, Alonso-Dominguez JM, Araujo MC, Coll AP, Hernandez-Boluda JC, García-Gutiérrez V. Luna A, et al. Among authors: perez lamas l. Ann Hematol. 2022 Oct;101(10):2263-2270. doi: 10.1007/s00277-022-04932-6. Epub 2022 Aug 23. Ann Hematol. 2022. PMID: 35997804 Free PMC article.
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.
Rodríguez-Mora S, Pérez-Lamas L, Sainero MS, Torres M, Sánchez-Menéndez C, Corona M, Mateos E, Casado-Fernández G, Alcamí J, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, García-Gutiérrez V, Coiras M. Rodríguez-Mora S, et al. Among authors: perez lamas l. Cancers (Basel). 2023 Apr 18;15(8):2344. doi: 10.3390/cancers15082344. Cancers (Basel). 2023. PMID: 37190272 Free PMC article.
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
Pérez-Lamas L, Moreno-Jiménez G, Tenorio-Núñez MC, Velázquez-Kennedy K, Jiménez-Chillón C, Astibia-Mahillo B, Núñez-Torrón C, García-Gutiérrez V, Jiménez-Martín A, Vallés-Carboneras A, López-Jiménez JF. Pérez-Lamas L, et al. Am J Hematol. 2021 Aug 1;96(8):E288-E291. doi: 10.1002/ajh.26214. Epub 2021 May 15. Am J Hematol. 2021. PMID: 33939851 Free PMC article. No abstract available.
Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection.
Vigón L, Sánchez-Tornero A, Rodríguez-Mora S, García-Pérez J, Corona de Lapuerta M, Pérez-Lamas L, Casado-Fernández G, Moreno G, Torres M, Mateos E, Murciano-Antón MA, Alcamí J, Pérez-Olmeda M, López-Jiménez J, García-Gutiérrez V, Coiras M, On Behalf Of Multidisciplinary Group Of Study Of Covid-Mgs-Covid. Vigón L, et al. Among authors: perez lamas l. J Clin Med. 2022 Apr 11;11(8):2137. doi: 10.3390/jcm11082137. J Clin Med. 2022. PMID: 35456230 Free PMC article.
Differentiation Syndrome in a Patient With Acute Promyelocytic Leukemia: Importance of Chest CT.
Gorospe Sarasúa L, Ventura-Díaz S, Ayala-Carbonero AM, Gambí-Pisonero E, Sánchez-Tornero de la Cruz A, Pérez-Lamas L, Mirambeaux-Villanova RM, Chinea-Rodríguez A. Gorospe Sarasúa L, et al. Among authors: perez lamas l. Arch Bronconeumol (Engl Ed). 2020 May;56(5):326-327. doi: 10.1016/j.arbres.2019.11.004. Epub 2019 Dec 28. Arch Bronconeumol (Engl Ed). 2020. PMID: 31892449 English, Spanish. No abstract available.
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib.
Pérez-Lamas L, Díaz AS, Casterá EM, Soto MH, Coll AP, De Las Heras N, Cortes M, Tenza PV, Pacho MS, Magan AS, Angona A, Cervero C, de Paz R, Cuenca AS, Santaliestra M, Marín JL, Casado LF, García-Gutiérrez V. Pérez-Lamas L, et al. Ann Hematol. 2024 Nov;103(11):4537-4544. doi: 10.1007/s00277-024-05906-6. Epub 2024 Sep 13. Ann Hematol. 2024. PMID: 39269475 Free PMC article.
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.
Pérez-Lamas L, de Paz Arias R, Díaz RMA, Montero LFC, Payer ÁR, Sierra M, Marín FF, López RP, Cirici BX, Steegmann JL, Gómez Casares MT, Martínez-López J, García-Gutiérrez V. Pérez-Lamas L, et al. Ann Hematol. 2024 Oct;103(10):4045-4055. doi: 10.1007/s00277-024-05662-7. Epub 2024 Apr 3. Ann Hematol. 2024. PMID: 38568260 Clinical Trial.